Streetbeat News

Products Services

AMAT

QQQ

SPY

Applied Materials (AMAT) stock is rising due to a 4.63% increase following a rate cut by the Federal Open Market Committee. The rate cut benefits growth stocks and rate-sensitive sectors like tech, making it cheaper for semiconductor companies to finance projects, boosting demand for AMAT's equipment. Lower rates also increase the present value of future earnings, making growth companies more attractive to investors.

Portfolio Pulse from Henry Khederian

September 19, 2024 | 2:51 pm

ELWS

Earlyworks Co., Ltd. (NASDAQ:ELWS) has entered into a business alliance with CAICA DIGITAL Inc. to support the expansion of Web3 businesses. This partnership aims to provide comprehensive support to businesses engaged in Web3 projects.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:47 pm

NKE

Nike Inc (NYSE:NKE) shares rose by 1.2% following a 50 basis point interest rate cut by the Federal Reserve. Rate cuts can boost consumer spending on discretionary items like Nike products and reduce Nike's borrowing costs, potentially increasing profitability. Nike's global market presence may benefit if other central banks follow suit, enhancing consumer spending in emerging markets.

Portfolio Pulse from Henry Khederian

September 19, 2024 | 2:46 pm

GLMD

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares surged after announcing plans to expand drug development with two new programs targeting cancer and cardiac fibrosis. The company will release new data in Q4. GLMD is a low-float stock, contributing to its volatility.

Portfolio Pulse from Adam Eckert

September 19, 2024 | 2:39 pm

VNDA

The FDA has declined Vanda Pharmaceuticals' NDA for tradipitant, a treatment for gastroparesis, citing the need for additional studies. The FDA's decision was delayed and did not meet legal requirements. Vanda plans to continue pursuing approval and will submit a separate NDA for motion sickness.

Portfolio Pulse from Vandana Singh

September 19, 2024 | 2:33 pm

PRU

Prudential Financial has launched a Stop Loss Insurance product to help employers with self-funded medical plans manage the risk of high medical claim payouts. This product allows companies to cap their healthcare spending and transfer claims volatility to Prudential.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:33 pm

DUOL

Duolingo (NASDAQ:DUOL) has seen a surge in bullish options activity, with significant trades indicating a price target range of $220 to $330. The stock is currently up 4.58% at $261.69, with analysts maintaining positive ratings. The next earnings report is expected in 48 days.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 2:31 pm

ADI

AMAT

AMD

NVDA

QCOM

Semiconductor and chip stocks are experiencing a rise in share prices following a recent rate cut, which has positively impacted growth stocks and rate-sensitive sectors like technology.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:29 pm

ACHL

Achilles Therapeutics shares rise as the company discontinues its TIL-based cNeT program, closes Phase I/IIa CHIRON and THETIS trials, and shifts strategy to explore third-party engagements.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:29 pm

FLGC

Flora Growth Corp. (NASDAQ:FLGC) has announced a supply agreement with Blossom Genetics to introduce Colombian medical cannabis strains to the German market. This move is part of Flora's strategy to expand its presence in Europe, following its acquisition of TruHC Pharma GmbH. Flora has been active in Germany since 2017 and holds an EU-GMP facility with access to over 1,200 pharmacies. The company's shares rose by 6.6762% following the announcement.

Portfolio Pulse from Jelena Martinovic

September 19, 2024 | 2:28 pm